Study examines family lineage of King Tut, his possible cause of death – Malaria and bone abnormalities appear to have contributed to the death of Egyptian pharaoh King Tutankhamun, revealed by researchers.
Clustering MRSA in Europe indicates diffusion through regional health-care networks – A new study finds that methicillin-resistant Staphylococcus aureus (MRSA) ?responsible for several difficult-to-treat infections including blood poisoning and pneumonia and a particular problem in hospitals ? occurs in distinct geographical clusters across Europe, indicating that MRSA is being diffused by patients moving between hospitals rather than spreading freely in the community.
Brain imaging may help diagnose autism — Subtle language delay, visible in MEG, may flag disorder – Children with autism spectrum disorders (ASDs) process sound and language a fraction of a second slower than children without ASDs, and measuring magnetic signals that mark this delay may become a standardized way to diagnose autism.
FDA Approves ACTEMRA? (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis – Genentech, Inc. , a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA? (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.
Can kitchen spoons be dangerous spoons? — Do not rely upon kitchen spoons when measuring liquid medicine. Cornell study shows we pour too little or too much medicine, depending on spoon size. – A new research led by Dr. Brian Wansink, director of the Cornell Food and Brand Lab, shows we should not rely upon kitchen spoons when measuring liquid medicine. The study shows we pour too little or too much medicine, depending on spoon size.
New SBI and ACR recommendations suggest breast cancer screening should begin at age 40 – Breast cancer screening should begin at age 40 and earlier in high-risk patients, suggested by the Society of Breast Imaging (SBI) and the American College of Radiology (ACR).
Insect cells provide the key to alternative swine flu vaccination — New production method can meet the demand of a global flu pandemic – Scientists in Vienna have developed a new technique for producing vaccines for H1N1, ‘swine flu’, based on insect cells. The research, published today in the Biotechnology Journal, reveals how influenza vaccines can be produced faster than through the traditional method of egg-based production, revealing a new strategy for the fight against influenza pandemics.
Assessing lead time of selected ovarian cancer biomarkers – Concentrations of the biomarkers CA125, human epididymis protein 4 (HE4), and mesothelin began to rise 3 years before clinical diagnosis of ovarian cancer, according to a new study published online December 30 in the Journal of the National Cancer Institute.
Researchers discover new ‘golden ratios’ for female facial beauty – Beauty is not only in the eye of the beholder but also in the relationship of the eyes and mouth of the beholden. The distance between a woman’s eyes and the distance between her eyes and her mouth are key factors in determining how attractive she is to others.
CSIR completes first ever Human Genome Sequencing in India – The Council of Scientific and Industrial Research (CSIR) has achieved completion of first ever Human Genome Sequencing in India. Scientist of CSIR at the Institute of Genomics and Integrative Biology (IGIB), Delhi have sequenced the Human Genome of an anonymous healthy Indian citizen.
Cooling may benefit children after cardiac arrest — Multicenter study evaluates effectiveness of therapeutic hypothermia in extending survival and reducing brain injury. – When the heart is stopped and restarted, the patient’s life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient’s body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.
FDA Approves Kalbitor for Treating Potentially Life-Threatening Attacks of Hereditary Angioedema – The U.S. Food and Drug Administration approved Kalbitor (ecallantide) to treat sudden and potentially life-threatening fluid buildup that can occur in people with a rare genetic condition known as hereditary angioedema (HAE).
